Sarcomas: New Treatment Approach with DDR-Inhibition

We are exploring a new combined treatment for patients with sarcomas to see if it is safe and effective. This study aims to improve treatment options for those affected by this type of cancer.

>2 yearsSafety phase (I)OncologyOrthopedics and Traumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Radiotherapy
Amstelveen, Netherlands
Leids Universitair Medisch Centrum (LUMC)
Radiotherapy
Leiden, Netherlands
Radboud universitair medisch centrum / RADBOUDUMC
Medical Oncology
Nijmegen, Netherlands
Sponsor: Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.